COMMUNIQUÉS West-GlobeNewswire

Accrelist Ltd. Unveils New Vision for Asian Aesthetic Medicine Expansion, A.M Aesthetics Targets 100 Clinics by 2029
11/09/2026
Singapore, Singapore, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Accrelist Ltd. has unveiled a new long-term growth vision for its medical aesthetics brand, A.M Aesthetics , outlining plans to accelerate its expansion across [...]
Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
11/09/2026
Kensington, MD, USA and Munich/Martinsried, Germany, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Kensington, MD, USA, and Munich/Martinsried, Germany, September 11 , 2026 – Galimedix Therapeutics, Inc. (“Galimedix”), a Phase 2 [...]
Mark Holland se joint à la Fondation pour la santé des hommes au Canada à titre de l’un de ses nouveaux membres du conseil d’administration
11/09/2026
VANCOUVER, Colombie-Britannique, 11 sept. 2026 (GLOBE NEWSWIRE) -- L’ancien ministre fédéral de la Santé Mark Holland se joint à l’une des principales organisations canadiennes vouées à la santé des hommes à titre de [...]
Mark Holland Joins Canadian Men’s Health Foundation As One Of Its Newest Board Members
11/09/2026
VANCOUVER, British Columbia, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Former Health Minister, Mark Holland, joins a leading men’s health organization, as one of its newest board members. Mark Holland joins the Canadian Men’s [...]
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
11/09/2026
View the video webcast here SAN DIEGO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
GENFIT va intégrer les indices CAC Mid 60 et SBF 120 d’Euronext Paris
11/09/2026
Lille (France), Cambridge (Massachusetts, États-Unis), le 11 septembre 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie [...]
GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
11/09/2026
Lille (France), Cambridge (Massachusetts, United States), September 11, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver [...]
Nicox annonce l’acceptation pour examen en Chine de la NDA de NCX 470
11/09/2026
Communiqué de presse Nicox annonce l’acceptation pour examen en Chine de la NDA de NCX 470 L’acceptation du dossier de NCX 470 marque le début du processus d’examen réglementaire Une décision réglementaire est attendue [...]
Nicox Announces NCX 470 NDA in China Accepted for Review
11/09/2026
Press Release Nicox Announces NCX 470 NDA in China Accepted for Review Acceptance of the NCX 470 dossier initiates the review process Regulatory decision expected within 12-18 months from the August submission Q&A [...]
Persica Pharmaceuticals publishes new analysis of assay sensitivity in disc microbiology studies, reinforcing the potential for PP353 in vertebrogenic Lumbar Back Pain
11/09/2026
Publication strengthens the scientific rationale for PP353 as a precisely targeted, non-opioid treatment for patients with vertebrogenic Lumbar Back Pain Manuscript submitted to the European Spine Journal and is [...]
Resolution Therapeutics completes enrollment in Phase I/II EMERALD clinical trial evaluating RTX001 in end-stage liver disease
11/09/2026
15 patients dosed with RTX001, an engineered Regenerative Macrophage Therapy designed to address inflammation and fibrosis EMERALD is evaluating safety and efficacy of RTX001 in patients with end-stage liver disease and [...]
Avance Clinical Wins ANZCham's Australia-Taiwan Business Excellence Award in Taiwan
11/09/2026
TAIPEI, Taiwan, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Avance Clinical Taiwan has won the Australia-Taiwan Business Excellence Award at the 2026 Australia New Zealand Chamber of Commerce in Taiwan (ANZCham Taiwan) Business [...]
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), today announced that the Company granted a non-qualified stock option to purchase up to 275,000 shares of the Company’s [...]
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
10/09/2026
NEWTON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic [...]
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
10/09/2026
● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ● CALGARY, Alberta, Sept. 10, 2026 (GLOBE NEWSWIRE) -- XORTX [...]
Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
10/09/2026
Technology transfer to LyFE Manufacturing Center™ completed following FDA review of improved manufacturing process and updated analytical methods Dosing of additional patients with the new process at LyFE continues with [...]
Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
HUNTSVILLE, AL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug [...]
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
10/09/2026
GAITHERSBURG, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive [...]
COSCIENS ACQUIRES NUALTIS CORP.
10/09/2026
TORONTO, ONTARIO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) is pleased to announce the acquisition of Nualtis Corp. (“ Nualtis ”), a Montreal [...]

Pages